Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management

Immune checkpoint inhibitor (ICI) associated cardiovascular adverse events (CVAE) have become more frequent with the growing use of cancer immunotherapy. CVAEs include a wide spectrum of diseases such as myocarditis, pericarditis, heart failure, arrhythmias, coronary artery disease, and hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarifa, Abdulrazzak, Kim, Jin Wan, Lopez-Mattei, Juan, Palaskas, Nicolas, Iliescu, Cezar, Kim, Peter Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2021
Materias:
State of the Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263294/
https://www.ncbi.nlm.nih.gov/pubmed/34227272
http://dx.doi.org/10.4070/kcj.2021.0089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263294/
https://www.ncbi.nlm.nih.gov/pubmed/34227272
http://dx.doi.org/10.4070/kcj.2021.0089

Ejemplares similares